Skip to main content
SpringerLink
Log in
Book cover

Thyroid Cancer pp 745–750Cite as

Adjunctive Local Approaches to Thyroid Nodules and Metastatic Thyroid Cancer

  • Chapter
  • First Online:

  • 118 Accesses

Abstract

The overwhelming majority of differentiated thyroid cancers are curable, and this optimistic outlook applies particularly to stage I, II, and most stage III tumors. Stage IV tumors are typically and clearly in a different category, as the prognosis is significantly worse once distant metastases are present. In the author’s view, a worse prognosis is not a justification for therapeutic nihilism but instead demands more aggressive therapy, with the hopeful expectation of improving outcome and prognosis. Not infrequently, some stage I and II patients have local disease that is resistant to ablation by conventional surgery and radioiodine.

This is a preview of subscription content, log in via an institution.

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   129.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD   169.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD   249.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

References

  1. Bennedbaek FN, Hegedus L. Treatment of recurrent thyroid cysts with ethanol: a randomized double-blind controlled trial. J Clin Endocrinol Metab. 2003;88:5773–7.

    Article  CAS  PubMed  Google Scholar 

  2. Guglielmi R, Pacella CM, Bianchini A, et al. Percutaneous ethanol injection treatment in benign thyroid lesions: role and efficacy. Thyroid. 2004;14:125–31.

    Article  CAS  PubMed  Google Scholar 

  3. Valcalvi R, Frasoldati A. Ultrasound-guided percutaneous ethanol injection therapy in thyroid cystic nodules. Endocrinol Pract. 2004;10:269–75.

    Article  Google Scholar 

  4. Shin JE, Baek JH, Lee JH. Radiofrequency and ethanol ablation for the treatment of recurrent thyroid cancers: current status and challenges. Curr Opin Oncol. 2013;25:14–9.

    Article  CAS  PubMed  Google Scholar 

  5. Gangi A, Kastler B, Klinkert A, Dietemann JL. Injection of alcohol into bone metastases under CT guidance. J Comput Assist Tomogr. 1994;18:932–5.

    Article  CAS  PubMed  Google Scholar 

  6. Lewis BD, Hay ID, Charboneau JW, et al. Percutaneous ethanol injection for treatment of cervical lymph node metastases in patients with papillary thyroid carcinoma. Am J Roentgenol. 2002;178:699–704.

    Article  CAS  Google Scholar 

  7. Hay I, Charboneau W, Lewis B, et al. Successful ultrasound-guided percutaneous ethanol ablation of neck nodal metastases in 20 patients with postoperative TNM Stage I papillary thyroid carcinoma resistant to conventional therapy. Los Angeles: 74th Meeting, American Thyroid Association. 2002. Abstract 176.

    Google Scholar 

  8. Nakada K, Kasai K, Watanabe Y, et al. Treatment of radioiodine-negative bone metastasis from papillary thyroid carcinoma with percutaneous ethanol injection therapy. Ann Nucl Med. 1996;10:441–4.

    Article  CAS  PubMed  Google Scholar 

  9. Lim CY, Yun J-S, Lee J, Nam K-H, Chung WY, Park CS. Percutaneous ethanol injection therapy for locally recurrent papillary thyroid carcinoma. Thyroid. 2007;17:347–50.

    Article  CAS  PubMed  Google Scholar 

  10. Monchik JM, Donatini G, Iannuccilli J, Dupuy DE. Radiofrequency ablation and percutaneous ethanol injection treatment for recurrent local and distant well-differentiated thyroid carcinoma. Ann Surg. 2006;244:296–304.

    Article  PubMed  PubMed Central  Google Scholar 

  11. Sohn Y-M, Hong SW, Kim E-Y, Kim MJ, Moon HJ, Kim SJ, et al. Complete eradication of metastatic lymph node after percutaneous ethanol injection therapy: pathologic correlation. Thyroid. 2009;19:317–9.

    Article  PubMed  Google Scholar 

  12. Kim BM, Kim MJ, Kim EK, Park SI, Park CS, Chung WY. Controlling recurrent papillary thyroid carcinoma in the neck by ultrasonography-guided percutaneous ethanol injection. Eur Radiol. 2008;18:835–42.

    Article  PubMed  Google Scholar 

  13. Fromigue J, DeBaere T, Baudin E, Dromain C, Leboulleux S, Schlumberger M. Chemoembolization for liver metastases from medullary thyroid carcinoma. J Clin Endocrinol Metab. 2006;91:2496–9.

    Article  CAS  PubMed  Google Scholar 

  14. Kalinowski M, Dressler M, Konig A, El-Sheik M, Rinke A, Hoffken H, et al. Selective internal radiotherapy with Yttrium-90 microspheres for hepatic metastatic neuroendocrine tumors: a prospective single center study. Digestion. 2009;79:137–42.

    Article  PubMed  Google Scholar 

  15. Schlumberger M, Challeton C, De Vathaire F, et al. Radioactive iodine treatment and external radiotherapy for lung and bone metastases from thyroid carcinoma. J Nucl Med. 1996;37:598–605.

    CAS  PubMed  Google Scholar 

  16. Muresan MM, Olivier P, Leclere J, Sirveaux F, Brunaud L, Klein M, et al. Bone metastases from differentiated thyroid carcinoma. Endocr Relat Cancer. 2008;15:37–49.

    Article  CAS  PubMed  Google Scholar 

  17. Bernier M-O, Leenhardt L, Hoang C, et al. Survival and therapeutic modalities in patients with bone metastases of differentiated thyroid carcinoma. J Clin Endocrinol Metab. 2001;86:1568–73.

    Article  CAS  PubMed  Google Scholar 

  18. Camille RR, Leger FA, Merland JJ, et al. Recent advances in the treatment of bone metastases from cancer of the thyroid. Chirurgie. 1980;106:32–6.

    CAS  PubMed  Google Scholar 

  19. Smit JW, Vielvoye GJ, Goslings BM. Embolization for vertebral metastases of follicular thyroid carcinoma. J Clin Endocrinol Metab. 2000;85:989–94.

    Article  CAS  PubMed  Google Scholar 

  20. Vitale G, Fonderico F, Martignetti A, et al. Pamidronate improves the quality of life and induces clinical remission of bone metastases in patients with thyroid cancer. Br J Cancer. 2001;84:1586–90.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  21. Rosen HN, Moses AC, Garber J, et al. Randomized trial of pamidronate in patients with thyroid cancer: bone density is not reduced by suppressive doses of thyroxine, but is increased by cyclic intravenous pamidronate. J Clin Endocrinol Metab. 1998;83:2324–30.

    CAS  PubMed  Google Scholar 

  22. Rosen LS, Gordon D, Tchekmedyian S, et al. Zoledronic acid versus placebo in the treatment of skeletal metastases in patients with lung cancer and other solid tumors: a phase III, double-blind, randomized trial—the zoledronic acid lung cancer and other solid tumors study group. J Clin Oncol. 2003;21:3150–7.

    Article  CAS  PubMed  Google Scholar 

  23. Rosen LS, Gordon D, Tchekmedyian NS, et al. Long-term efficacy and safety of zoledronic acid in the treatment of skeletal metastases in patients with non-small cell lung carcinoma and other solid tumors. Cancer. 2004;100:2613–21.

    Article  CAS  PubMed  Google Scholar 

  24. Eustatia-Rutten CF, Romijn JA, Guijt MJ, et al. Outcome of palliative embolization of bone metastases in differentiated thyroid carcinoma. J Clin Endocrinol Metab. 2003;88:3184–9.

    Article  CAS  PubMed  Google Scholar 

  25. Van Tol KM, Hew JM, Jager PL, et al. Embolization in combination with radioiodine therapy for bone metastases from differentiated thyroid carcinoma. Clin Endocrinol. 2000;52:653–9.

    Article  Google Scholar 

  26. Elshafie O, Hussein S, Jeans WD, Woodhouse NJ. Massive rise in thyroglobulin with adult respiratory distress syndrome after embolisation of thyroid cancer metastasis. Br J Radiol. 2000;73:547–9.

    Article  CAS  PubMed  Google Scholar 

  27. Halpin RJ, Bendok BR, Liu JC. Minimally invasive treatments for spinal metastases: vertebroplasty, kyphoplasty, and radiofrequency ablation. J Support Oncol. 2004;2:339–55.

    PubMed  Google Scholar 

  28. Peh WC, Gilula LA. Percutaneous vertebroplasty: indications, contraindications, and technique. Br J Radiol. 2003;76:69–75.

    Article  CAS  PubMed  Google Scholar 

  29. Kushchayev S, Kushchayev Y, Theodore N, Preul MC, Clark OH. Percutaneous vertebroplasty for thyroid cancer metastases to the spine. Thyroid. 2010;20:555–60.

    Article  PubMed  Google Scholar 

  30. Ahmad Z, Abbasi F, Mitsunaga M, Portner B. Pain reduction and functional improvement after kyphoplasty: a retrospective study of 50 patients. Archit Phys Med Rhab. 2003;84:A21.

    Article  Google Scholar 

  31. Ledlie JT, Fenfro M. Balloon kyphoplasty: one-year outcomes in vertebral body height restoration, chronic pain, and activity levels. J Neurosurg. 2003;98:36–42.

    PubMed  Google Scholar 

  32. Faggiano A, Ramundo V, Assanti AP, Fonderic PE, Macchia PE, Misso C, et al. Thyroid nodules treated with percutaneous radiofrequency thermal ablation: a comparative study. J Clin Endocrinol Metab. 2012;97:4439–45.

    Article  CAS  PubMed  Google Scholar 

  33. Huh JY, Baek JH, Choi H, Kim JK, Lee JH. Symptomatic benign thyroid nodules: efficacy of additional radiofrequency ablation treatment session – prospective randomized study. Radiology. 2012;263:909–16.

    Article  PubMed  Google Scholar 

  34. Na DG, Lee JH, Jung SL, Kim JH, Sung JY, Shin JH, et al. Radiofrequency ablation of benign thyroid nodules and recurrent thyroid cancers: consensus statement and recommendations. Kor J Radiol. 2012;13:117–25.

    Article  Google Scholar 

  35. Ha JH, Baek J, Lee JH. The efficacy and complications of radiofrequency of thyroid nodules. Curr Opin Endocrinol Diabetes Obes. 2011;18:310–4.

    Article  PubMed  Google Scholar 

  36. Wallace LB, Berber E. Percutaneous and video-assisted ablation of endocrine tumors: liver, adrenal and thyroid. Surg Lap, Endosc Percutan Tech. 2011;21:255–9.

    Article  Google Scholar 

  37. Baek JH, Lee JH, Valcavi R, Pacella CM, Rhim H, Na DG. Thermal ablation for benign thyroid nodules: radiofrequency and laser. Kor J Radiol. 2011;12:525–40.

    Article  Google Scholar 

  38. McGahan JP, Dodd GD. Radiofrequency ablation of the liver: current status. Am J Roentgenol. 2001;176:3–16.

    Article  Google Scholar 

  39. Dupuy DE. Minimally invasive therapies in the treatment of bone malignancies. Crit Rev. 1998;75:161–71.

    Google Scholar 

  40. Goetz MP, Callstrom MR, Charboneau JW, et al. Percutaneous image-guided radiofrequency ablation of painful metastases involving bone: a multicenter study. J Clin Oncol. 2004;22:300–6.

    Article  PubMed  Google Scholar 

  41. Schaefer O, Lohrmann C, Ghanem N, Langer M. CT-guided radiofrequency heat ablation of malignant lung tumors. Med Sci Monit. 2003;9:127–31.

    Google Scholar 

  42. Dupuy DE, Zagoria RJ, Akerley W, et al. Percutaneous radiofrequency ablation of malignancies in the lung. Am J Roentgenol. 2000;174:57–9.

    Article  CAS  Google Scholar 

  43. Berber E, Siperstein A. Laparoscopic radiofrequency thermal ablation of adrenal tumors: technical details. Surg Laparosc Endosc Percutan Tech. 2010;20:58–62.

    Article  PubMed  Google Scholar 

  44. Schaefer O, Lohrmann C, Markmiller M, et al. Technical innovation: combined treatment of a spinal metastasis with radiofrequency heat ablation and vertebroplasty. Am J Roentgenol. 2003;180:1075–7.

    Article  Google Scholar 

  45. Halpin RJ, Bendok BB, Sato KT, et al. Combination treatment of vertebral metastases using image-guided percutaneous radiofrequency ablation and vertebroplasty: a case report. Surg Neurol. 2005;63:469–74.

    Article  PubMed  Google Scholar 

  46. Dupuy DE, Monchik JM, Decrea C, Pisharodi L. Radiofrequency ablation of regional recurrence from well-differentiated thyroid malignancy. Surgery. 2001;130:971–7.

    Article  CAS  PubMed  Google Scholar 

  47. Callstrom MR, Charboneau JW, Goetz MP, et al. Painful metastases involving bone: feasibility of percutaneous CT- and US-guided radio-frequency ablation. Radiology. 2002;224:87–97.

    Article  PubMed  Google Scholar 

  48. Mazzaglia PJ, Berber E, Milas M, Siperstein AE. Laparoscopic radiofrequency ablation of neuroendocrine liver metastases: a 10-year experience evaluating predictors of survival. Surgery. 2007;142:10–9.

    Article  PubMed  Google Scholar 

  49. Akyildiz HY, Mitchell J, Milas M, Siperstein A, Berber E. Laparoscopic radiofrequency thermal ablation of neuroendocrine hepatic metastases: long-term follow-up. Surgery. 2010;148:1288–93.

    Article  PubMed  Google Scholar 

  50. Berber E, Siperstein A. Local recurrence after laparoscopic radiofrequency ablation of liver tumors: an analysis of 1032 tumors. Ann Surg Oncol. 2008;15:2757–64.

    Article  PubMed  Google Scholar 

  51. Pacella CM, Bizzarri G, Ferrari FS, et al. Interstitial photocoagulation with laser in the treatment of liver metastases. Radiol Med. 1996;92:438–47.

    CAS  PubMed  Google Scholar 

  52. Pacella CM, Bizzarri G, Magnolfi F, et al. Laser thermal ablation in the treatment of small hepatocellular carcinoma: results in 74 patients. Radiology. 2001;221:712–20.

    Article  CAS  PubMed  Google Scholar 

  53. Papini E, Bizzarri G, Pacella CM. Percutaneous laser ablation of benign and malignant thyroid nodules. Curr Opin Endocrinol Diabetes Obes. 2008;15:434–9.

    Article  PubMed  Google Scholar 

  54. Guglielmi R, Pacella CM, Dottorini MF, et al. Severe thyrotoxicosis due to hyperfunctioning liver metastases from follicular carcinoma treatment with 131-I and interstitial laser ablation. Thyroid. 1999;9:173–7.

    Article  CAS  PubMed  Google Scholar 

  55. Pacella CM, Bizzarri G, Guglielmi R, et al. Thyroid tissue: US-guided percutaneous interstitial laser ablation—a feasibility study. Radiology. 2000;217:673–7.

    Article  CAS  PubMed  Google Scholar 

  56. Papini E, Guglielmi R, Gharib AH, Misischi I, Graziano F, Chianelli M, et al. Ultrasound-guided laser ablation of incidental papillary thyroid microcarcinoma: a potential therapeutic approach in patients at surgical risk. Thyroid. 2011;21:917–20.

    Article  PubMed  PubMed Central  Google Scholar 

  57. Valcavi R, Piana S, Bortolan GS, Lai R, Barbieri V, Negro R. Ultrasound-guided percutaneous laser ablation of papillary thyroid microcarcinoma: a feasibility study on three cases with pathological and immunohistochemical evaluation. Thyroid. 2013;23:1578–82.

    Article  PubMed  Google Scholar 

  58. Pacella CM, Bizzari G, Spiezia S, et al. Thyroid tissue: US-guided percutaneous laser thermal ablation. Radiology. 2004;232:272–80.

    Article  PubMed  Google Scholar 

  59. Cakir B, Topaloglu O, Gul K, Agac T, Aydin C, Dirikoc A, et al. Ultrasound-guided percutaneous laser ablation treatment in inoperable aggressive course anaplastic thyroid carcinoma: the introduction of a novel alternative palliative therapy-second experience in the literature. J Endocrinol Invest. 2007;30:624–5.

    Article  CAS  PubMed  Google Scholar 

  60. Esnault O, Franc B, Chapelon J-Y. Localized ablation of thyroid tissue by high-intensity focused ultrasound: improvement of noninvasive tissue necrosis methods. Thyroid. 2009;19:1085–91.

    Article  PubMed  Google Scholar 

  61. Esnault, Franc B, Menegaux F, Rouxel A, DeKerviler E, Bourrier P, Lacoste F, et al. High-intensity focused ultrasound ablation of thyroid nodules: first human feasibility study. Thyroid. 2011;21:965–73.

    Article  PubMed  Google Scholar 

  62. Leenhardt L, Borson-Chazot F, Calzada B, Carnaille A, Charrie B, Cochand-Priollet CD, et al. Good practice guide for cervical ultrasound scan and echo-guided techniques in treating differentiated thyroid cancer of vesicular origin. Ann Endocrinol. 2011;72:173–97.

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Medicine, MedStar Washington Hospital Center, Georgetown University School of Medicine, 110 Irving Street, N.W., Washington, DC, 20010-2975, USA

    Leonard Wartofsky MD, MACP

Authors
  1. Leonard Wartofsky MD, MACP
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Leonard Wartofsky MD, MACP .

Editor information

Editors and Affiliations

  1. Department of Medicine, MedStar Washington Hospital Center Georgetown University School of Medicine, Washington, DC, USA

    Leonard Wartofsky

  2. Nuclear Medicine Research MedStar Research Institute and Washington Hospital Center, Georgetown University School of Medicine Washington Hospital Center, Washington, DC, USA

    Douglas Van Nostrand

Rights and permissions

Reprints and permissions

Copyright information

© 2016 Springer Science+Business Media New York

About this chapter

Cite this chapter

Wartofsky, L. (2016). Adjunctive Local Approaches to Thyroid Nodules and Metastatic Thyroid Cancer. In: Wartofsky, L., Van Nostrand, D. (eds) Thyroid Cancer. Springer, New York, NY. https://doi.org/10.1007/978-1-4939-3314-3_67

Download citation

  • DOI: https://doi.org/10.1007/978-1-4939-3314-3_67

  • Published:

  • Publisher Name: Springer, New York, NY

  • Print ISBN: 978-1-4939-3312-9

  • Online ISBN: 978-1-4939-3314-3

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation